Construct: ORF ccsbBroadEn_10801

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF002488.1_s300c1, BRDN0000394817
DNA Barcode:
None
Epitope Tag:
None
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
EPB41 (2035)

Vector Information:

Vector Backbone:
pDONR223
Pol II Cassette 1:
n/a
Pol II Cassette 2:
n/a
Selection Marker:
n/a
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 2035 EPB41 erythrocyte membrane protei... NM_203342.2 97% 97% 1217_1273del
2 human 2035 EPB41 erythrocyte membrane protei... NM_001166007.2 96.6% 96.6% 1216_1217ins63
3 human 2035 EPB41 erythrocyte membrane protei... NM_004437.4 94.5% 94.5% 1585_1586ins102
4 human 2035 EPB41 erythrocyte membrane protei... XM_017000598.1 81.1% 71.3% (many diffs)
5 human 2035 EPB41 erythrocyte membrane protei... XM_017000602.1 80.6% 75.4% (many diffs)
6 human 2035 EPB41 erythrocyte membrane protei... XM_017000603.1 80.2% 75.4% (many diffs)
7 human 2035 EPB41 erythrocyte membrane protei... XM_017000604.1 80.1% 75.2% (many diffs)
8 human 2035 EPB41 erythrocyte membrane protei... XM_017000599.1 79.4% 74.8% (many diffs)
9 human 2035 EPB41 erythrocyte membrane protei... XM_017000600.1 79.3% 74.7% (many diffs)
10 human 2035 EPB41 erythrocyte membrane protei... XM_017000594.1 78.8% 78.8% 1459_1959del
11 human 2035 EPB41 erythrocyte membrane protei... XM_017000595.1 76.6% 76.3% (many diffs)
12 human 2035 EPB41 erythrocyte membrane protei... XM_017000596.1 76.1% 76.1% 1216_1217ins63;1396_1896del
13 human 2035 EPB41 erythrocyte membrane protei... XM_017000597.1 76% 76% 1007_1008insAGC;1213_1214ins63;1393_1893del
14 human 2035 EPB41 erythrocyte membrane protei... XM_011540964.1 75.6% 75.6% 1214_1312del;1558_2058del
15 human 2035 EPB41 erythrocyte membrane protei... XM_017000593.1 75.5% 75.5% 1007_1008insAGC;1211_1309del;1555_2055del
16 human 2035 EPB41 erythrocyte membrane protei... XM_005245764.1 74.8% 74.8% 1_627del
17 human 2035 EPB41 erythrocyte membrane protei... XM_005245763.1 73.1% 73.1% 1_627del;1844_1900del
18 human 2035 EPB41 erythrocyte membrane protei... XM_005245765.1 72.8% 72.4% (many diffs)
19 human 2035 EPB41 erythrocyte membrane protei... XM_005245769.1 72.3% 72.3% 1_627del;1843_1844ins63
20 human 2035 EPB41 erythrocyte membrane protei... XM_005245770.1 72.2% 72.2% 1_627del;1634_1635insAGC;1840_1841ins63
21 human 2035 EPB41 erythrocyte membrane protei... NM_001166005.1 71.9% 71.9% 1_627del;1841_1939del
22 human 2035 EPB41 erythrocyte membrane protei... XM_005245761.1 71.9% 71.9% 1_627del;1841_1939del
23 human 2035 EPB41 erythrocyte membrane protei... XM_017000586.1 71.7% 71.4% (many diffs)
24 human 2035 EPB41 erythrocyte membrane protei... XM_024453880.1 71.4% 71.4% 52_53ins105;1109_1207del;1453_1953del
25 human 2035 EPB41 erythrocyte membrane protei... XM_006710439.1 71% 71% 1_627del;1841_1939del;2185_2220del
26 human 2035 EPB41 erythrocyte membrane protei... XM_005245760.1 70.6% 70.6% 1_627del;1841_1939del;2185_2235del
27 human 2035 EPB41 erythrocyte membrane protei... NM_203343.3 68.1% 68.1% 1_627del;679_680ins105;1738_1739ins63
28 human 2035 EPB41 erythrocyte membrane protei... XM_017000589.1 68.1% 68.1% 1_627del;679_680ins105;1738_1739ins63
29 human 2035 EPB41 erythrocyte membrane protei... XM_017000590.1 67.9% 67.9% (many diffs)
30 human 2035 EPB41 erythrocyte membrane protei... XM_005245774.1 67.1% 67.1% 1_627del;1843_1844ins63;2022_2023ins129
31 human 2035 EPB41 erythrocyte membrane protei... XM_005245768.1 67% 67% 1_627del;1841_1939del;2184_2185ins129
32 human 2035 EPB41 erythrocyte membrane protei... XM_011540960.1 62.3% 62.3% 1_627del;2086_2586del
33 human 2035 EPB41 erythrocyte membrane protei... XM_011540963.2 61.9% 55% (many diffs)
34 human 2035 EPB41 erythrocyte membrane protei... XM_005245757.1 61.7% 61.4% (many diffs)
35 human 2035 EPB41 erythrocyte membrane protei... XM_005245753.1 61.3% 61.3% 1_627del;1841_1939del;2185_2634del
36 human 2035 EPB41 erythrocyte membrane protei... XM_011540959.1 61.1% 61.1% 1_627del;1844_1900del;2143_2643del
37 human 2035 EPB41 erythrocyte membrane protei... XM_011540958.1 61.1% 61.1% 1_627del;1841_1939del;2185_2646del
38 human 2035 EPB41 erythrocyte membrane protei... XM_011540961.1 60.7% 60.3% (many diffs)
39 human 2035 EPB41 erythrocyte membrane protei... XM_006710434.1 60.6% 60.6% 1_627del;1841_1939del;2185_2670del
40 human 2035 EPB41 erythrocyte membrane protei... XM_005245772.4 60.4% 57% (many diffs)
41 human 2035 EPB41 erythrocyte membrane protei... XM_011540956.1 60.3% 60.3% 1_627del;1841_1939del;2185_2685del
42 human 2035 EPB41 erythrocyte membrane protei... XM_017000584.2 60.3% 60.3% 1_627del;1841_1939del;2185_2685del
43 human 2035 EPB41 erythrocyte membrane protei... XM_017000587.1 60.3% 56.8% (many diffs)
44 human 2035 EPB41 erythrocyte membrane protei... XM_017000591.1 60.3% 56.7% (many diffs)
45 human 2035 EPB41 erythrocyte membrane protei... XM_005245773.4 60.2% 56.8% (many diffs)
46 human 2035 EPB41 erythrocyte membrane protei... XM_011540957.1 60.2% 60.2% (many diffs)
47 human 2035 EPB41 erythrocyte membrane protei... XM_011540962.1 60.2% 60.2% 1_627del;1843_1844ins63;2023_2523del
48 human 2035 EPB41 erythrocyte membrane protei... XM_017000585.2 60.2% 60.2% 1_627del;1843_1844ins63;2023_2523del
49 human 2035 EPB41 erythrocyte membrane protei... XM_017000588.1 60.1% 56.7% (many diffs)
50 human 2035 EPB41 erythrocyte membrane protei... XM_017000592.1 60.1% 56.6% (many diffs)
51 human 2035 EPB41 erythrocyte membrane protei... XM_011540965.3 60.1% 56.6% (many diffs)
52 human 2035 EPB41 erythrocyte membrane protei... XM_017000583.1 60.1% 60.1% (many diffs)
53 human 2035 EPB41 erythrocyte membrane protei... NM_001166006.1 57.6% 57.2% (many diffs)
54 human 2035 EPB41 erythrocyte membrane protei... XM_017000581.1 56.9% 56.9% (many diffs)
55 human 2035 EPB41 erythrocyte membrane protei... XM_017000582.1 56.8% 56.8% (many diffs)
56 mouse 269587 Epb41 erythrocyte membrane protei... XM_017320241.1 88.2% 93.7% (many diffs)
57 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538910.3 86.3% 91.6% (many diffs)
58 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538909.3 85.6% 90.9% (many diffs)
59 mouse 269587 Epb41 erythrocyte membrane protei... NM_001128607.1 84.9% 90.3% (many diffs)
60 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538912.3 84.8% 90.3% (many diffs)
61 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538908.3 83.8% 89% (many diffs)
62 mouse 269587 Epb41 erythrocyte membrane protei... XM_017320237.1 71.3% 75.5% (many diffs)
63 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538899.3 69.7% 73.8% (many diffs)
64 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538900.3 69.6% 73.8% (many diffs)
65 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538916.3 69.2% 66.8% (many diffs)
66 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538913.3 68.8% 69.9% (many diffs)
67 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538915.3 68.7% 69.7% (many diffs)
68 mouse 269587 Epb41 erythrocyte membrane protei... XM_017320238.1 68.6% 72.7% (many diffs)
69 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538897.3 68.3% 72.4% (many diffs)
70 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538896.3 68.1% 72.1% (many diffs)
71 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538895.3 67.3% 71.3% (many diffs)
72 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538901.3 67.1% 71.2% (many diffs)
73 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538902.3 67% 71.2% (many diffs)
74 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538893.3 66.9% 70.9% (many diffs)
75 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538894.3 66.8% 70.9% (many diffs)
76 mouse 269587 Epb41 erythrocyte membrane protei... NM_001128606.1 63.5% 67.5% (many diffs)
77 mouse 269587 Epb41 erythrocyte membrane protei... NM_183428.3 63.5% 67.3% (many diffs)
78 mouse 269587 Epb41 erythrocyte membrane protei... XM_017320243.1 63.4% 67.5% (many diffs)
79 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538917.3 62.8% 66.6% (many diffs)
80 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538911.3 55.2% 58.7% (many diffs)
81 mouse 269587 Epb41 erythrocyte membrane protei... XM_017320239.1 54.1% 57.2% (many diffs)
82 mouse 269587 Epb41 erythrocyte membrane protei... XM_006538907.3 53.3% 56.4% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
69
ORF end:
1935
ORF length:
1866
Sequence:
1gttcgttgca acaaattgat gagcaatgct tttttataat gccaacttTG TACAAGAAAG
61TTGGCACCAT GCACTGCAAG GTTTCTTTGT TGGATGACAC AGTTTATGAA TGTGTTGTGG
121AGAAACATGC TAAGGGACAA GATTTGCTTA AACGAGTATG TGAGCATCTC AATCTTTTGG
181AAGAAGACTA TTTTGGTCTA GCCATTTGGG ATAACGCAAC CTCTAAGACA TGGCTGGATT
241CCGCCAAAGA AATAAAAAAG CAGGTTCGTG GTGTCCCTTG GAATTTTACA TTTAATGTAA
301AGTTTTATCC ACCTGACCCA GCACAGTTAA CAGAAGACAT AACAAGATAT TATTTATGTC
361TTCAGCTTCG GCAGGACATA GTTGCAGGAC GTCTGCCCTG TTCCTTTGCA ACCTTAGCAT
421TATTAGGTTC TTACACCATC CAGTCTGAAC TGGGAGACTA CGACCCAGAA CTCCATGGCG
481TGGATTATGT TAGTGATTTT AAACTGGCCC CGAATCAGAC CAAGGAACTT GAAGAGAAGG
541TCATGGAACT GCATAAGTCA TACAGGTCCA TGACTCCAGC TCAGGCTGAC TTGGAGTTTC
601TTGAGAATGC CAAAAAGTTG TCTATGTATG GAGTTGATCT TCATAAAGCA AAGGACTTGG
661AAGGAGTAGA TATCATCCTA GGTGTCTGCT CTAGTGGCCT TCTGGTTTAC AAAGATAAGC
721TGAGAATTAA CCGCTTCCCT TGGCCCAAAG TGCTGAAGAT TTCTTATAAA CGTAGTAGCT
781TTTTCATCAA GATTCGGCCT GGAGAGCAAG AGCAGTATGA AAGTACCATC GGATTCAAAC
841TTCCCAGTTA CCGAGCAGCT AAGAAATTAT GGAAAGTCTG TGTAGAACAT CACACGTTTT
901TCAGATTGAC ATCTACAGAC ACCATTCCCA AAAGCAAATT TCTTGCGCTA GGATCCAAAT
961TTCGATACAG TGGCCGGACT CAAGCTCAGA CCAGGCAAGC TAGTGCTCTA ATTGACAGGC
1021CTGCCCCACA CTTCGAGCGT ACAGCAAGTA AACGGGCGTC CCGGAGCCTC GATGGAGCAG
1081CAGCTGTCGA TTCGGCAGAC CGAAGTCCTC GGCCCACTTC TGCACCTGCC ATTACTCAGG
1141GTCAGGTTGC AGAAGGTGGC GTCCTAGATG CCTCTGCTAA AAAAACAGTG GTCCCTAAAG
1201CACAGAAGGA AACAGTGAAG GCTGAAGTGA AAAAGGAAGA CGAGCCACCT GAGCAAGCTG
1261AGCCAGAGCC CACAGAAGCA TGGAAGAAAA AGAGAGAAAG ACTAGATGGT GAAAACATTT
1321ATATCAGACA TAGCAATTTA ATGTTGGAGG ATTTAGACAA GAGTCAAGAG GAGATCAAAA
1381AACATCATGC CAGCATCAGT GAGCTGAAAA AGAACTTCAT GGAGTCTGTA CCAGAACCAC
1441GGCCTAGTGA ATGGGATAAA CGCTTATCCA CTCACTCACC CTTCCGAACT CTTAACATCA
1501ATGGGCAAAT CCCCACAGGA GAAGGACCTC CCCTGGTGAA GACACAAACT GTCACCATCT
1561CAGATAATGC CAATGCTGTG AAAAGTGAAA TCCCAACCAA AGACGTCCCT ATTGTCCACA
1621CTGAGACCAA GACCATCACT TATGAGGCTG CCCAGACTGA CGACAACAGT GGAGACTTGG
1681ACCCAGGAGT CTTGCTGACA GCTCAAACTA TCACATCTGA GACCCCAAGC AGCACCACCA
1741CAACTCAAAT TACCAAGACT GTAAAAGGTG GGATTTCAGA GACACGTATT GAAAAGAGAA
1801TTGTGATCAC AGGAGATGCT GATATTGACC ATGATCAGGT CCTTGTACAA GCCATCAAGG
1861AGGCAAAGGA GCAGCACCCA GACATGTCAG TGACCAAGGT GGTCGTCCAC CAGGAGACCG
1921AGATTGCTGA TGAGTTGCCA ACTTTCTTGT ACAAAGTtgg cattataaga aagcattgct
1981tatcaatttg ttgcaacgaa c

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.